脑微出血作为死亡预测因素:Framingham心脏研究
该研究评估1963名无卒中及痴呆的Framingham参与者,利用脑磁共振成像和死亡数据,采用Cox比例风险模型分析脑微出血与全因、心血管及卒中相关死亡的关系。结果显示脑微出血患病率8.9%,平均随访7.2±2.6年观察到296例死亡;年龄性别调整后脑微出血与全因死亡风险增加相关(HR 1.39,95%CI 1.03-1.88),但进一步调整心血管风险因素和预防用药后不再显著(HR 1.15,95%CI 0.82-1.63)。
要点
- 脑微出血在社区无卒中痴呆人群中患病率8.9%。
- 年龄性别调整后脑微出血与全因死亡风险增加相关。
- 调整心血管风险及预防用药后关联不再显著。
核心结论
- 脑微出血可能反映心血管风险因素对脑血管的损害效应。
- 其存在与全因死亡增加相关,但校正血管风险因素和预防治疗使用后关联消失。
- 需进一步研究明确心血管预防治疗对偶发脑微出血者死亡预防的作用。
研究设计与样本
- 研究纳入1963名Framingham原始及后代队列参与者,平均年龄67岁,54%为女性,均有脑磁共振成像和死亡数据。
- 采用Cox比例风险模型分析脑微出血与全因、心血管及卒中相关死亡的关系。
主要发现
- 脑微出血参与者(8.9%)心血管风险因素患病率和预防药物使用率更高。
- 平均随访7.2±2.6年期间观察到296例死亡。
- 年龄和性别调整分析中,脑微出血与全因死亡风险增加相关(HR 1.39,95%CI 1.03-1.88)。
- 进一步调整心血管风险因素和预防药物使用后,关联不再显著(HR 1.15,95%CI 0.82-1.63)。
临床怎么用
- 脑微出血可作为心血管风险负担的影像标志物,提示评估和管理血管风险因素。
- 对于偶发脑微出血者,优化心血管预防治疗可能有助于降低死亡风险,但需进一步研究证实。
局限性
- 研究为观察性设计,无法确立因果关系。
- 脑微出血与死亡关联在调整血管风险因素后消失,提示残余混杂可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Cerebral microbleeds (CMB) represent a common magnetic resonance imaging marker of cerebral small vessel disease, increasingly recognized as a subclinical marker of stroke and dementia risk. CMB detection may reflect the cumulative effect of vascular risk burden and be a marker of higher mortality. We investigated the relation of CMB to risk of death in community dwelling participants free of stroke and dementia. METHODS: We evaluated 1963 Framingham Original and Offspring Cohort participants (mean age 67 years; 54% women) with available brain magnetic resonance imaging and mortality data. Using Cox proportional hazards models, we related CMB to all-cause, cardiovascular, and stroke-related mortality. RESULTS: Participants with CMB (8.9%) had higher prevalence of cardiovascular risk factors and use of preventive medications. During a mean follow-up of 7.2±2.6 years, we observed 296 deaths. In age- and sex-adjusted analysis, CMB were associated with increased all-cause mortality (hazards ratio, 1.39; 95% confidence interval 1.03-1.88), a relation that was no longer significant after adjustment for cardiovascular risk and preventive medication use (hazards ratio, 1.15; 95% confidence interval, 0.82-1.63). CONCLUSIONS: CMBs may represent the deleterious effect of cardiovascular risk factors in the cerebral vasculature. Although their presence was associated with increased all-cause mortality, the effect was no longer present after accounting for vascular risk factors and preventive treatment use. Further studies are required to clarify the role of cardiovascular preventive therapies for prevention of mortality in persons with incidental detection of CMB.
引用
- Romero JR, Preis SR, Beiser A, et al. Cerebral Microbleeds as Predictors of Mortality: The Framingham Heart Study. Stroke. 2017. PMID: 28143923. doi:10.1161/STROKEAHA.116.015354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。